Deadline on $100 Million NuvaRing Lawsuit Settlement Moved To March...

Merck & Co. Has Agreed to Pay $100 Million to Settle Thousands of NuvaRing Blood Clot Lawsuits Now Pending in State and Federal Courts, But it is Contingent on 95% Approval of Women Plaintiffs.(PRWeb March 18, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11680122.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news